Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAOK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IQCK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APLP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLANA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4G1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTBN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC23IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC5A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
USP13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGFG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BEST1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AAMDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBP8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on